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ABSTRACT 
Objective: To study the prescribing patterns of antihypertensive (AHT) drugs in hypertensive (HTN) patients and hypertension with diabetes 
mellitus (HTN with DM) patients in tertiary care hospital, to assess the rationality of prescribing patterns, to compare the hypertension 
management with Joint National Committee-7 guidelines (JNC-7). 
Methods: A prospective study was conducted over a period of 6 mo in the medicine department of Bharati Hospital and Research Centre, Pune. HTN 
and (HTN with DM patients. Who met the study criteria were enrolled in the study. The pattern of antihypertensive medications prescribed was 
studied and analyzed using Microsoft excel 2010 and Statistical. The rational prescribing pattern was assessed by using JNC 7 guidelines and World 
Health Organization (WHO) indicators. 
Results: Total of 60 patients included in this study, 43 (71.7 %) were HTN patients, and 17 (28.3 %) were HTN with DM patients. There were 29 
(48.33 %) males and 31 (51.66 %) female patients were involved. 45 % of patients had pre-hypertension, 33.33 % had stage-1 hypertension, 8.4 % 
had stage-2 hypertension other 13.33 % patients are on Antihypertensive medications and whose Blood Pressure (BP) were normal according to 
JNC-7. In hypertensive 47.05 % patient had prescribed Calcium Channel Blockers (CCBs) as monotherapy along with 87.5 % Angiotensin Receptor 
Blockers (ARBs) with diuretics as combination therapy. In HTN with DM 46.15 % patients had prescribed Angiotensin Converting Enzymes (ACEs) 
as monotherapy along with 62.5 % CCBs with BBs were prescribed according to JNC-7. As per WHO indicators, average no. of medicines prescribed 
per prescription was 2.91 and all antihypertensive medicines in the study population were prescribed rationally. 
Conclusion: The present study represents the current prescribing trend for antihypertensive agents. It implies that. In hypertensive patients ARBs 
are the leading group of antihypertensive agents as monotherapy and ARBs with diuretics as a combination therapy according to JNC 7. 
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INTRODUCTION 
Hypertension is an important public health challenge because of 
associated morbidity and mortality caused by cardiovascular 
diseases. Hypertension is a very common chronic disease in rural 
and urban areas of today’s world, which needs continuous 
monitoring and treatment throughout the life [1]. 
It affects 26 % of the adult population worldwide. By 2025 it is 
projected that 29 % of world’s population (1.56 billion adults) will 
have Hypertension, 2000 over 972 million or 26.4 % of the adult 
population were estimated to have hypertension. India population 
accounts those 66 million Hypertensive patients (34 million are in 
urban areas and 32 million in rural areas) [1,2]. Hypertension is 
disproportionately higher in diabetics. In India the overall 
prevalence of Hypertension among individual is about 65 %. So it is 
very essential to control Hypertension in diabetes mellitus patients 
to prevent macrovascular and microvascular complications. Higher 
age along with socioeconomic, behavioral, stressful lifestyle and 
nutritional issues in people can lead to increased incidence of 
hypertension with diabetes mellitus [3]. 
Hypertensive patients with diabetes have low rates of blood 
pressure (BP) control and often required combination therapy. 
Approximately 2/3rd
Hypertension requires suitable treatment to minimize the 
cardiovascular complications. There are various guidelines available 
worldwide for treating hypertension. Some of them are JNC-7 
guidelines, British Hypertension Society Guidelines for Hypertension 
Management 2004 and WHO guidelines. The Joint National 
Committee (JNC 7) defines normal BP as a systolic BP less than 120 
mmHg and diastolic BP less than 80 mm Hg. It is clearly recognized 
that an increasing BP level is associated with a greater risk of heart 
attack, stroke and kidney disease. For persons aged 40-70 y, each 
increment of 20 mmHg in systolic BP or 10 mmHg in diastolic BP 
doubles the risk of cardiovascular disease across the entire range of 
BP range from 115/75 mmHg to 185/115 mmHg [4-6].  
 of people with diabetes do not reach 
recommended target blood pressure value of 130/80 mmHg, a much 
higher proportion than patients without diabetes mellitus [3]. 
The rational prescribing pattern is the use of the least number of drugs 
to obtain the best possible effects in the shorter period of time. The 
present prescription monitoring study of antihypertensive agents has 
undertaken in the Outpatient medicine department as well as 
Inpatient Department of a tertiary care hospital. The management of 
hypertension requires nonpharmacological as well as pharmacological 
methods. Pharmacological and non-pharmacological benefits can be 
achieved through the patient understanding of the disease, 
medications and lifestyle modifications. [5]. 
There is a need to be assessed the prescribing pattern in HTN as well 
as HTN with DM patients. The present prescription monitoring study 
of There is a need to be assessing the prescribing pattern in HTN as 
well as HTN with DM patients, The present prescription monitoring 
study of antihypertensive agents to promote efficient prescribing 
and proven to improve the rational use of medicines. If the 
difference seen in the prescribing pattern which helps to improve 
patient health status, helps inadequate control of hypertension and 
gives positive impacts of drugs on health status worldwide. 
MATERIALS AND METHODS 
The study was carried out at the Bharati Hospital (BH) and Research 
Center, Dhankawdi, Pune, Tertiary Care Hospital. It was a 
prospective study, approved by the Ethics Committee of Bharati 
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Medical College, Pune (BVDU/MC/14). The study was conducted for 
6 mo, i.e. from August 2014 to March 2015. In this study there were 
60 patients of either sex were included after taking written informed 
consent. The inclusion criteria for study subjects were 
Hypertensive patients above 18yrs male/female, Primary 
hypertensive patients with BP ≥160 (Systoli c) and ≥110 (Diastolic) 
and Hypertensive with diabetes mellitus patients. ICU patients, 
Hypertension with other Comorbid conditions patients, pregnant 
women were excluded. Demographic data and medicines were 
collected in the patient profile form. All the collected data were 
entered in Microsoft excel spreadsheet and prescriptions were 
analyzed, assessed and compared with the standard therapeutic 
guideline JNC 7. Assessment of all collected data was done with 
statistical analysis. Microsoft Excel 2010 was used to calculate the 
sets and interpret in terms of percentage, mean, the standard 
deviation was considered as significant. Microsoft Excel 2010 was 
used to calculate mean, the percentage of medications prescribed 
in patients. Standard deviation (SD) was used to calculate 
deviation in weight and age (years) groups of male and female in 
the study. Microsoft excel 2010 was also used for graphical 
presentation in the overall study. 
RESULTS 
A total of 60 patients included in this study, 43 (71.7 %) were 
primary hypertensive patients and 17 (28.3 %) were hypertensive 
with diabetes mellitus patients. There were 29 (48.33%) males and 
31 (51.66%) female patients were involved. (table 1), Maximum 
patients were within the age interval of 40-50 y (26.67%) and 
minimum were 30-40 y (11.66 %). (table 2). The family history of 
the patients revealed that majority of the patients (78.33%) does not 
have any family history of hypertension, followed by (21.66%) in 
whom there was underlying family history of Hypertension (table 3). 
The social habits of the study population were observed and found 
to be that, most of the patients were having the habit of cigarette 
smoking 9 (15 %) followed by 8 (13.33 %) were having chewing 
tobacco (fig. 1). 
In BH, most of the patients were diagnosed with pre-hypertension27 
(45%), stage 1 hypertension 20 (33.33%) and stage 2 hypertension5 
(8.33%) whose BP categorized according to JNC 7 (table 4) 
In hypertensive 47.05 % CCBs, 52.93 % patient had prescribed with 
ARBs as monotherapy (table 5) and 87.5 % patients were 
prescribed with ARBs+diuretics, 12.5% patients were prescribed 
with CCBs+BBs as combination therapy (table 7) according to JNC 
7. In hypertension with diabetes mellitus 53.84 % patients had 
prescribed with ACEs, 7.69% patient had prescribed with BBs, 
7.69 % patient had prescribed with CCBs, 30.76 % patient had 
prescribed with ARBs as monotherapy (table 6) and 62.5 % 
patient had prescribed with CCBs+BBs, 25 % patient had 
prescribed with CCBs+ARBs, 12.5 % patient had prescribed with 
ARBs+diuretics as combination therapy (table 8) were prescribed 
according to JNC 7. Out of 60 total prescriptions, there were 175 
prescribed drugs, i.e. 2.91 % medicines prescribed per encounter 
(table 9). 
All the AHT medicines prescribed in the study population were 
prescribed according to JNC 7 Guidelines (table 10). 
 
Table 1: Gender-wise distribution 
Gender Number of patients (n=60) Percentage (%) 
Male 29 48.33 
Female 31 51.66 
 
Table 2: Age-wise distribution of study population 
Age (years) No of patients (n=60) Percentage (%) 
30-40 7 11.66 
40-50 16 26.67 
50-60 12 20.01 
60-70 11 18.33 
70-80 14 23.33 
 
Table 3: Family history 
Category No. of patients (n=60) Percentage (%) 
Family history 13 21.66 
No family history 47 78.33 
 
Table 4: Classification of blood pressure category in study population according JNC 7 
Classification SBP (mmHg) DBP (mmHg) No. of patients (n=60) Percentage (%) 
Normal <120 <80 8 13.33 
Pre-hypertension 120-139 80-89 27 45 
Stage 1 140-159 90-99 20 33.33 
Stage 2 ≥160 ≥100 5 8.33 
 
Table no. 5: Monotherapy according to JNC 7 guidelines in HTN 
Drug Dose (mg) Frequency No. of patients (n=34) Percentage (%) 
Amlodipine 2.5,5 OD 16 47.05 
Telmisartan 20,40 OD 10 29.41 
Olmesartan 20 OD 8 23.52 
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Table 6: Monotherapy according to JNC 7 Guidelines in HTN with DM 
Drugs Dose (mg) Frequency No. of patients (n=13) Percentage (%) 
Enalapril 2.5, 5 OD 6 46.15 
Ramipril 25 OD 1 7.69 
Atenolol 40 OD 1 7.69 
Amlodipine 2.5,5 OD 1 7.69 
Telmisartan 20, 40 OD 3 23.07 
Olmesartan 20 OD 1 7.69 
 
Table 7: Combination therapy in HTN according to JNC 7 guidelines 
Combination therapy of drugs Dose (mg) Frequency No. of patients (n=8) Percentage (%) 
Telmisartan+Hydrochlorothiazide 40/5 or 40/12.5 OD 5 62.5 
Olmesartan+Hydrochlorothiazide 20/12.5 or 40/12.5 OD 2 25 
Amlodipine+Atenolol 5/25 OD 1 12.5 
 
Table 8: Combination therapy in HTN with DM according to JNC 7 guidelines 
Combination therapy Dose (mg) Frequency No. of patients (n=8) Percentage (%) 
Amlodipine+Atenolol 5/25 OD 4 50 
Amlodipine+Nebivolol 5/2.5 OD 1 12.5 
Amlodipine+Telmisartan 5/40 OD 1 12.5 
Amlodipine+Olmesartan 5/25 OD 1 12.5 
Telmisartan+Hydrochlorothiazide 40/5 OD 1 12.5 
 
Table 9: Assessment of rationality by using WHO indicators 
No. of 
prescription 
Total no. of medicines 
prescribed 
Average no. of medicines prescribed per 
prescription 
Recommendations (NMT 4 or more 
medicines prescribed/encounter) 
60 175 2.91 No polypharmacy 
 
Table 10: Percent (%) of medicines prescribed according to JNC 7 
Total of medicines prescribed 175 
Total no. of AHT medicines prescribed 63 
Out of 69 AHT medicines prescribed according to JNC 7 63 
Percent of medicines prescribed according to JNC 7 100% 
Recommendations 
(Medicines prescribed according to JNC 7) 
Rational prescribing pattern. 
 
 
Fig. 1: Social history 
 
DISCUSSION 
Our study includes 60 patients. Of these, 31 (51.66 %) were females, 
and 29 (48.33 %) were males, which suggests a number of female 
patients are more as compared to male patients which were a 
similar study conducted by [2]. Female cases were more occurrences 
due to lack of awareness, high salt intake and lifestyle modifications. 
Of the 60 Hypertensive and hypertensive with diabetes mellitus 
patients evaluated, a maximum number of patients16 (26.67 %) 
were within the age group 40-50 y, followed by 14 (23.33 %) were 
within the age group 60-70 y. A similar study carried out on the HTN 
patients showed that a maximum number of HTN patients belonged 
to the age group of 41-50 y and within the age group 60-70 y [2]. 
This could be because age is one of major risk factors and this age 
group has low rates of BP control.  
As per social habits, patients were concerned out of these 8 (13.33 
%) were having tobacco chewing, 9 (15 %) were having the habit of 
smoking among 4 (4.66 %) male patients were consuming alcohol 
was also observed in a study conducted by [7]. Cigarette Smoking is 
considered as a major risk factor for mortality in hypertension and 
in diabetes mellitus patients, drinking alcohol raise blood pressure 
and decrease the effectiveness of antihypertensive medications and 
increased a risk of stroke. 
In our study, it was found that about 21.66 % patients had a family 
history of HTN and HTN with DM followed by 78.33 % who did not 
have a family history. A similar study conducted by [17]. And it was 
reported that maximum patients had no history of hypertension. The 
reason could be a family history of hypertension reinforces the fact 
that there is a no strong genetic predisposition in hypertension [8]. 
In our study, most of the patients were diagnosed with Pre-
hypertension 27 (45 %), Stage-1 HTN 20 (33.33 %). In a study 
conducted by V. Pavani et al. in which most of the patients were 
diagnosed with Stage-1 HTN [8]. 
For the purpose of analyzing the prescribing patterns of 
antihypertensive drugs in the treatment of hypertension and HTN 
with diabetes mellitus, the pharmacotherapy was classified as 
monotherapy and combination therapy, In our study the prescribing 
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pattern in Hypertensive patients prescribed with monotherapy of 
ARBs (52.93 %), CCBs (47.05%) followed by ARBs+diuretics 
(87.5%). The study conducted by Mahanjit konwar et al. showed that 
CCBs is most commonly used drugs followed by ARBs. As per 
physicians, clinical empirical Practice ARBs were mostly prescribed 
because it is more beneficial first line Monotherapy. Combination 
therapy prescribed ARBs+Thiazide. CCBs were commonly 
prescribed because of better BP control, less incidence of side effects 
[9]. Thiazide diuretic given in combination with either CCBs, ARBs, 
BBs because they enhance the antihypertensive efficacy of multiple 
regimen and help to achieve blood pressure control [10]. 
In our study the prescribing pattern in Hypertensive with co-existing 
Diabetes mellitus patients prescribed with Monotherapy of ACEs 
53.84 %, ARBs 30.76 %, CCBs (7.96%) and combination therapy of 
CCBs+BBs were 62.5 %. A study conducted by J. Keerthi Sagar et al. 
showed that CCBs and ARBs drugs are most commonly used as 
Monotherapy followed by combination therapy of CCBs+BBs [11,12]. 
A similar study conducted by Y. N Clement et al., concluded that 
there was Angiotensin-converting enzyme inhibitors, Calcium 
Channel Blockers, B-blockers as monotherapy or CCBs with BBs as 
combination therapy, were more likely to be prescribed in diabetic 
hypertensive patients [13]. ACEs, CCBs, ARBs, and BBs in Diabetic 
hypertension are beneficial in reducing cardiovascular events and 
progression of kidney disease. ACEs or ARBs reduces the 
progression of protein urea [10]. Therefore initial, antihypertensive 
therapy for a patient with diabetes should ideally consist of an ACEs 
or ARBs first line as per JNC 7 guideline [10]. 
The average number of medicines prescribed per prescription in our 
study was found to be (2.91) Alam k et al., showed that the average 
number of drugs per prescription were found to be 2.91 which is 
exactly similar to our study and which is lesser as compared to other 
countries [14]. In our study all the AHT medicines were prescribed to 
study population was, according to JNC 7 Guidelines, i.e. found to be 
100 % [10]. 
CONCLUSION 
The present study represents the current prescribing trend for 
antihypertensive agents. It implies that In hypertensive patients 
ARBs are the leading group of antihypertensive agents as 
monotherapy and ARBs with diuretics as a combination therapy 
according to JNC 7. 
In hypertension with diabetes mellitus, ACEs are the leading group 
of antihypertensive agents as monotherapy and CCBs with BBs as 
combination therapy according to JNC 7. 
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